Saturday, November 22, 2014 Last update: 2:03 PM - Covering Large & Obscure Tech Companies Since 1996

Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market

Companies mentioned in this article: Decision Resources Group

BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States preclinical animal research imaging system market will be significantly driven by the trend toward multimodality imaging, such as combining computed tomography and magnetic resonance imaging with nuclear imaging and optical imaging. This demand stems from the need for higher-quality imaging to satisfy more stringent publication requirements among scientific journals, which will spur preclinical imaging system sales.

Other key findings from Decision Resources Group's coverage of the U.S. preclinical animal research imaging system market:

    --  Multimodality imaging: Currently, technical hurdles have precluded the
        development of integrated PET/MRI systems that allow for simultaneous
        multimodality imaging; therefore, sequential imaging is done on separate
        systems, which has driven sales of stand-alone units. However, as
        integrated systems improve and offer better imaging capabilities, there
        will be less of a need to purchase separate stand-alone systems.
    --  Funding for preclinical research: In recent years, a lack of funding for
        preclinical research has restricted system sales. However, funding
        levels are expected to gradually rebound through 2022, which will
        positively impact the preclinical imaging system market.
    --  Vendors working with customers in the grant process: To help facilities
        obtain funding for their research, preclinical vendors have researchers
        and grant writers on staff to support the grant process. This strategy
        can boost companies' brand loyalty among customers and fuel future
        system purchases.

Comments from Decision Resources Group Analyst Felix Lam:

    --  "Although preclinical and clinical imaging technologies are similar,
        very few players are active in both markets. Producing systems for
        medical use involves additional regulatory hurdles that can be costly;
        therefore, most of the smaller preclinical imaging system vendors only
        compete in the preclinical space."
    --  "The lack of overlap between preclinical and clinical vendors will be
        even more evident given the departure of major players, such as GE
        Healthcare and Siemens Healthcare, from the preclinical imaging market.
        This has created significant competitive volatility, with the remaining
        vendors aggressively competing for newly orphaned customers. Vendors
        will also need to invest in the marketing gap left by the exit of these
        large players."

Additional Resources:

    --  Felix Lam has written a Medtech 360 report on this subject entitled US
        Markets for Preclinical Animal Research Imaging Systems 2014.

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

Decision Resources Group
Christopher Comfort

Logo -

SOURCE Decision Resources Group